Directors
Martin Robinson – Non-Executive Chairman
Martin Robinson joined Plant Impact plc in June 2005 when he was appointed non-executive Chairman. He is the Executive Chairman of Braemar Group plc, a residential property investment fund manager and whose shares are quoted on AIM, a non-executive director at Regenesis Group plc, a short-term asset finance company and a non-executive director of several private companies. He was formally Chief Executive of both Lloyd Street Private Equity, an FSA regulated company that specializes in raising finance for growing companies and stockbroker and fund manager Henry Cooke Group plc and a director of private bank Brown, Shipley & Co. Ltd. In addition he is a Chartered Accountant.
Peter Blezard – Chief Executive Officer
Peter is a founder shareholder of the Company. He is a Fellow of the Royal Society of Arts, Manufacturers & Commerce. Peter has extensive experience in pioneering new products into new markets and in working with major companies on a global basis at board level. Previous roles include General Manager of Pak 2000, a division of Asia Pulp and Paper, between 1988 and 2000, where his core duties were European sales and marketing. His responsibilities also include working with national security agencies and meeting governments in Europe, Asia and the Far East. He also has experience in the strategic planning of new factories in Indonesia and China, with projects to ISO9000 standards. Peter co-founded Plant Impact plc in 2003, and has recently accepted the Bioentrepreneur award as sponsored by UK Trade & Investment and London First in recognition of our work to date.
Michael Panteli – Chief Financial Officer
Mike was appointed full-time Finance Director on 8 May 2007. He is a Chartered Management Accountant, has an economics and finance degree and has recently been awarded the ACCA diploma in International Financial Reporting. Mike moved from Intercytex Group plc, where he served as Financial Controller. During his six years at Intercytex, he was a key member of the finance and management teams overseeing the development of Intercytex from a venture capital backed biotechnology company through to admission to trading on AIM. Prior to Intercytex, he served as Financial Director of Telescope Technologies Limited, a manufacturer of large telescopes. He replaced Gordon Harman, who indicated, at the time of the admission of the Company to trading on AIM, that he wished to step down from the role of part-time Finance Director by mid-2007.
David McNeilly – Non-Executive Director
David McNeilly, 65, has over 42 years’ experience in Life Science related businesses, including 32 years with the DuPont Co. He works at the interface of technology and business development, especially in assessing how to add and capture value and in developing growth strategies. He has proven skills in leadership, strategic planning, marketing, sales and small business development. Although originally a botany graduate, the focus of David’s work at DuPont was mainly in the fields of agribusiness marketing, licensing and especially biotechnology, which he has concentrated on for the last 20 years. He recently held non-executive board positions in Alaska Diagnostics Ltd (food diagnostics), Avidis S.A. (therapeutics) and Prokyma Ltd (particle separation diagnostics).
Edward Sharkey– Non-Executive Director
Having gained his PhD in Chemistry from the University of Edinburgh, Edward Sharkey, 61, joined AH Marks, where he spent the majority of his career in the agro-chemical industry. He progressed to the main board where as an executive director he was instrumental in the building of a Performance Chemicals business with a team of 12 scientists. Most recently he founded Ambechem Ltd. a management consultancy business operating in the agro-chemical sector. Presently Edward chairs a number of global task forces as well as several international businesses, and has a wealth of experience in the regulatory and registration process. He is a director of Ambechem Ltd
Creative Science without Compromise™
